MARKER THERAPEUTICS INC's ticker is and the CUSIP is 57055L957. A total of 1 filers reported holding MARKER THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $0 | – | 100 | -93.3% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 1,500 | -60.5% | 0.00% | – |
| Q1 2022 | $1,000 | -75.0% | 3,800 | -20.8% | 0.00% | – |
| Q4 2021 | $4,000 | -94.1% | 4,800 | -79.9% | 0.00% | – |
| Q3 2021 | $68,000 | +3.0% | 23,900 | 0.0% | 0.00% | – |
| Q2 2021 | $66,000 | -14.3% | 23,900 | +6767.8% | 0.00% | – |
| Q1 2021 | $77,000 | – | 348 | +34700.0% | 0.00% | – |
| Q4 2020 | $0 | -100.0% | 1 | -94.1% | 0.00% | – |
| Q2 2020 | $3,000 | -66.7% | 17 | -64.6% | 0.00% | – |
| Q1 2020 | $9,000 | -66.7% | 48 | -48.9% | 0.00% | – |
| Q4 2019 | $27,000 | -89.2% | 94 | -80.7% | 0.00% | -100.0% |
| Q3 2019 | $249,000 | +289.1% | 488 | +495.1% | 0.00% | – |
| Q2 2019 | $64,000 | – | 82 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |